Journal
BLOOD
Volume 133, Issue 22, Pages 2359-2364Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2018-12-852830
Keywords
-
Categories
Funding
- European Research Council [H2020-MSCA 765492, 713727, 336540]
- Netherlands Organisation for Scientific Research [91711366]
- Dutch Cancer Society [VU2015-8080]
- European Research Council (ERC) [713727] Funding Source: European Research Council (ERC)
Ask authors/readers for more resources
Liquid biopsies have been considered the holy grail in achieving effective cancer management, with blood tests offering a minimally invasive, safe, and sensitive alternative or complementary approach for tissue biopsies. Currently, blood-based liquid biopsy measurements focus on the evaluation of biomarker types, including circulating tumor DNA, circulating tumor cells, extracellular vesicles (exosomes and oncosomes), and tumor-educated platelets (TEPs). Despite the potential of individual techniques, each has its own advantages and disadvantages. Here, we provide further insight into TEPs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available